Phenotypical and Genotypical Comparison of <i>Clostridium difficile</i> Isolated from Clinical Samples: Homebrew DNA Fingerprinting versus Antibiotic Susceptibility Testing (AST) and Clostridial Toxin Genes

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Antibiotics</td><td class="align_center">%</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left"><i>β</i>-Lactams</td><td class="align_center"> </td></tr><tr><td class="align_left"> Meropenem</td><td class="align_center">27.4</td></tr><tr><td class="align_left"> Imipenem</td><td class="align_center">15.5</td></tr><tr><td class="align_left"> Ceftriaxone</td><td class="align_center">9.5</td></tr><tr><td class="align_left"> Cefepime</td><td class="align_center">2.3</td></tr><tr><td class="align_left"> Ceftazidime</td><td class="align_center">1.2</td></tr><tr><td class="align_left"> Ampicillin/sulbactam</td><td class="align_center">1.2</td></tr><tr><td class="align_left"> Piperacillin</td><td class="align_center">1.2</td></tr><tr><td class="align_left">Glycopeptides</td><td class="align_center"> </td></tr><tr><td class="align_left"> Vancomycin</td><td class="align_center">16.6</td></tr><tr><td class="align_left">Metronidazole</td><td class="align_center"> </td></tr><tr><td class="align_left"> Metronidazole</td><td class="align_center">15.5</td></tr><tr><td class="align_left">Colistin</td><td class="align_center">4.8</td></tr><tr><td class="align_left">Lincosamides</td><td class="align_center"> </td></tr><tr><td class="align_left"> Clindamycin</td><td class="align_center">3.6</td></tr><tr><td class="align_left">Fluoroquinolone</td><td class="align_center"> </td></tr><tr><td class="align_left"> Ciprofloxacin</td><td class="align_center">1.2</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Percentage of antibiotic classes used for treatment in 2–8 weeks prior sampling.</div>

Canadian Journal of Infectious Diseases and Medical Microbiology

tab2

Table 2

Table 2: Phenotypical and Genotypical Comparison of <i>Clostridium difficile</i> Isolated from Clinical Samples: Homebrew DNA Fingerprinting versus Antibiotic Susceptibility Testing (AST) and Clostridial Toxin Genes 

Table 2 | Phenotypical and Genotypical Comparison of Clostridium difficile Isolated from Clinical Samples: Homebrew DNA Fingerprinting versus Antibiotic Susceptibility Testing (AST) and Clostridial Toxin Genes 